The association between tumor necrosis factor alpha promoter polymorphisms and ankylosing spondylitis: A meta-analysis

被引:15
作者
Ma, Bo [1 ,2 ,3 ]
Yang, Bing [3 ]
Guo, Hainiu [3 ]
Wang, Yihong [3 ]
Zhang, Dayi [3 ]
Zhang, Yuan [3 ]
Xiao, Zhengquan [3 ]
机构
[1] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100193, Peoples R China
[2] Peking Union Med Coll, Beijing 100193, Peoples R China
[3] Beijing Beiya Orthoped Hosp, Dept Orthoped, Beijing 102445, Peoples R China
关键词
TNF-ALPHA; GENE POLYMORPHISM; POSITION; -308; SUSCEPTIBILITY; REGION; SPONDYLOARTHRITIS; HLA-B27; DISEASE; RISK; THERAPY;
D O I
10.1016/j.humimm.2013.06.037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Studies investigating the association between tumor necrosis factor (TNF)-alpha promoter polymorphisms and ankylosing spondylitis have reported conflicting results. We here performed a meta-analysis based on the evidence currently available from the literature to make a more precise estimation of this relationship. Methods: We performed a systematic search of the National Library of Medline and Embase databases before January 2013. This meta-analysis included 14 case-control studies, which included 1607 ankylosing spondylitis cases and 1910 controls. Results: The combined results based on all studies showed that ankylosing spondylitis cases had a significantly lower frequency of -308GA [OR (codominant model) = 0.81, 95% CI = 0.66, 0.99, P = 0.04], -857CT [OR (codominant model) = 0.55, 95% CI = 0.32, 0.94, P = 0.03], -863AA [OR (codominant model) = 0.11, 95% CI = 0.01, 0.94, P = 0.04], -863CA [OR (codominant model) = 0.32, 95% CI = 0.18, 0.58, P < 0.001], and -1031TC [OR (codominant model) = 0.44, 95% CI = 0.25, 0.77, P = 0.004] genotype. However, ankylosing spondylitis cases had a significantly higher frequency of -238AA [OR (recessive model) = 7.43, 95% CI = 3.66, 15.05, P < 0.001] and -850TT [OR (recessive model) = 2.49, 95% CI = 1.16, 5.34, P = 0.02; OR (codominant model) = 2.83, 95% CI = 1.28, 6.25, P = 0.01] genotype. In the subgroup analysis by race, we found that ankylosing spondylitis cases had a significantly higher frequency of -238AA [OR (recessive model) = 7.43,95% CI = 3.66, 15.05, P < 0.001] genotype in Caucasians and lower frequency of -857CT [OR (codominant model) = 0.53, 95% Cl = 0.30, 0.94, P = 0.03] in Asians. Conclusions: Our meta-analysis suggests that TNF-alpha promoter polymorphisms at positions -238, -308, -850, -857, -863 and -1031 could have a small influence on ankylosing spondylitis susceptibility. But there is a lack of association of the TNF-alpha-376G/A and -646G/A polymorphisms with ankylosing spondylitis. (c) 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1357 / 1362
页数:6
相关论文
共 46 条
[1]  
Binbin C, 2011, EUR J HUM GENET, V19, P432, DOI [10.1038/ejhg.2010.159, DOI 10.1038/EJHG.2010.159]
[2]   Persistent clinical efficacy and safety of anti-tumour necrosis factor a therapy with infliximab in patients with ankylosing spondylitis over 5 years:: evidence for different types of response [J].
Braun, J. ;
Baraliakos, X. ;
Listing, J. ;
Fritz, C. ;
Alten, R. ;
Burmester, G. ;
Krause, A. ;
Schewe, S. ;
Schneider, M. ;
Soerensen, H. ;
Zeidler, H. ;
Sieper, J. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (03) :340-345
[3]   Ankylosing spondylitis [J].
Braun, Juergen ;
Sieper, Joachim .
LANCET, 2007, 369 (9570) :1379-1390
[4]  
Braun N, 1996, NEUROSCI LETT, V215, P75, DOI 10.1016/S0304-3940(96)12920-7
[5]  
BREWERTON DA, 1973, LANCET, V1, P904
[6]  
Chatzikyriakidou A, 2009, CLIN EXP RHEUMATOL, V27, P645
[7]   The association between seven ERAP1 polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis involving 8,530 cases and 12,449 controls [J].
Chen, Rui ;
Yao, Lei ;
Meng, Tong ;
Xu, Weidong .
RHEUMATOLOGY INTERNATIONAL, 2012, 32 (04) :909-914
[8]   Polymorphisms of tumor necrosis factor-α promoter region for susceptibility to HLA-B27-positive ankylosing spondylitis in Korean population [J].
Chung, Won-Tae ;
Choe, Jung-Yoon ;
Jang, Won Cheoul ;
Park, Su Min ;
Ahn, Young Chang ;
Yoon, Il Kyu ;
Kim, Tae-Hwan ;
Nam, Youn-Hyoung ;
Park, Sung-Hoon ;
Lee, Sung-Won ;
Kim, Seong-Kyu .
RHEUMATOLOGY INTERNATIONAL, 2011, 31 (09) :1167-1175
[9]   Review article: joint involvement in inflammatory bowel disease [J].
De Vos, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 :36-42
[10]   Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis [J].
Duan, Zhenhua ;
Pan, Faming ;
Zeng, Zhen ;
Zhang, Tianchen ;
Wang, Sheng ;
Li, Guixing ;
Xu, Shengqian ;
Xu, Jianhua ;
Zhang, Li .
RHEUMATOLOGY INTERNATIONAL, 2012, 32 (05) :1209-1214